Default company panoramic image


Vax-Immune develops commercial products to diagnose, treat and prevent Ureaplasma infection.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Houston, TX, USA
  • Currency USD
  • Founded April 2011
  • Employees 3
  • Website

Company Summary

Ureaplasma infects up to 50% of people & cattle and results in miscarriage, infertility, premature birth, urinary tract infection, prostatitis, & more. Ureaplasma diagnosis is: not available at the point of care (POC); time consuming; expensive. Our diagnostic kit is: used at the POC; rapid; cost-effective. Antibiotics have limited efficacy & significant side-effects. Our treatment and prevention products are effective with minimal side-effects.


  • Default avatar
    Leonard E. Weisman
    President and Chief Science Officer

    Professor of Pediatrics at Baylor College of Medicine (BCM) and Texas Children’s Hospital (TCH). His record of successful productive research, extramural funding, leadership, scientific expertise and experience prepares him to lead the scientific development of this company.

  • Default avatar
    Joaquin Altenberg
    Chief Executive and Chief Financial Officer

    Managing Partner of Vert Investment Group LLC; graduated from Harvard Business School in 2002; holds Securities Series 7, 24, 63, 79, and 99 licenses. He has extensive experience in financial management of portfolio companies in technology, energy and financial industries. His record of financial transactions, business development, and fund raising for these companies prepares him to lead the financial development of this company.